课题基金 / 基金详情

SAFETY AND EFFICACY OF ORAL TRIAZOLAM IN CHILDREN

SAFETY AND EFFICACY OF ORAL TRIAZOLAM IN CHILDREN
儿童口服三唑仑的安全性和有效性
批准号:
2749352
负责人:
MARTHA SPIEKER
金额:
$3.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-08-01 至 1999-07-31

项目摘要

项目成果

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The safety and efficacy of most oral benzodiazepines for sedation of children is unknown. Yet, there is ample evidence that adverse events occur with unfortunate regularity during sedation in dental care settings with children. This study is a randomized double blind clinical trial where 96 three-to-five year-old children are assigned to either active drug (o.015 or 0.03 mg/kg) or placebo before dental treatment. The objective of the research is to establish the efficacy, safety, and optimal dosing regimen for oral triazolam in pediatric sedation, a paradigm for surgical premedication, in order to provide a rational clinical pharmacological basis for the use this drug which is commonly used yet currently unapproved. The specific aims are: a. To determine the efficacy of oral triazolam administered as a premedication to children in dental practice in comparison to a placebo. b. To assess the safety of oral triazolam in children. c. To study visual and memory side effects of triazolam in children.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文